Matt Bryant
Company: Boston Pharmaceuticals
Job title: Vice President
Seminars:
Panel Discussion | Translating GLP-1s, Rezmiteron, FGF21 Therapies into Clinical Practice Guidelines in a Rapidly Changing Landscape 3:30 pm
Assessing how current therapies fit into the standard of care Navigating the future of combination therapies to optimize treatment Evaluating how this will play out in the real world with access, non-responders, standard of care and the shift to primary care providersRead more
day: Conf Day 1 EOD